CancerNetwork®(@CancerNetwrk):Daraxonrasib has been approved for metastatic pancreatic cancer. We saw that coming. The RAS-agnostic indication? That was a bit of a surprise. ⬇️ We spoke with Nicholas Hornstein, MD, PhD (@GIMedOnc), about it! https://t.co/8eRoBe2uN3 #pancsm #oncology #cancer

CancerNetwork®

@CancerNetwrk

Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.

Joined February 2009

781 Following 30.2K Followers

CancerNetwork®@CancerNetwrk

2026.08.27 17:15

Daraxonrasib has been approved for metastatic pancreatic cancer. We saw that coming. The RAS-agnostic indication? That was a bit of a surprise. ⬇️ We spoke with Nicholas Hornstein, MD, PhD (@GIMedOnc), about it! #pancsm# #oncology# #cancer#